Prof. Dr. med. Claudia Dorothea Baldus

Facts

Phone: +49-431-500-22501
E-Mail: claudia.baldus@uksh.de
Affiliations: Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address: Arnold-Heller-Str. 3, Bldg L

Curriculum vitae

Education/Training

Since 10/2018Director of Medicine, Hematology and Oncology, Christian-Albrechts-University Kiel, Medical Center Schleswig-Holstein, Campus Kiel, Germany
2009-2018Senior Attending Physician, Dept. of Hematology and Oncology, Charité, Berlin 
99-01,03-09Resident, Charité, University Medicine Berlin, Germany
2000Dr. med. (Thesis in medicine)
1992-1999Medical School, Universities of Homburg and Berlin, Germany

Research Experience/Academic Appointments

2020Vice Dean of the medical Faculty of the CAU, Christian-Albrechts-University, Kiel
2020Director of the University Cancer Center Schleswig-Holstein (UCCSH)
2018Full Professor of Medicine, Hematology and Oncology, Christian-Albrechts-University, Kiel
2011-2016Professor (W3) of Hematology, Mildred-Scheel Stiftungsprofessur, Charité Berlin
2005-2011Max-Eder-Nachwuchsgruppenförderung, CBF Charité Berlin
2001-2003Post-doctoral fellow, Human Cancer Genetics Program, OSU, Columbus, USA (Mildred-Scheel Stipendiat)

Important Scientific Prizes/Functions

2017-2019Speaker Joint Research Project – DKTK Joint Funding project 
2015-2019Speaker Joint Research Project – German Cancer Aid, Translational Oncology
Since 2011Head of the trial research committee (GMALL Study Group)

Research groups

Project-related publications

P1, P3, P4, INF, Z

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

Bastian L, Hartmann AM, Beder T, Hänzelmann S, Kässens J, Bultmann M, Hoeppner MP, Franzenburg S, Wittig M, Franke F, Nagel I, Spielmann M, Reimer N, Busch H, Schwartz S, Steffen B, Viardot A, Döhner K, Kondakci M, Wulf G,  Wendelin K, Renzelmann A, Kiani A, Trautmann H, Neumann M, Gökbuget N, Brüggemann M, Baldus CD

PubMed (PMID: 35397658)
Leukemia
2022
P1, P4, INF

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity

Das Gupta D, Paul C, Samel N, Bieringer M, Staudenraus D, Marini F, Raifer H, Menke L, Hansal L, Camara B, Roth E,  Daum P, Wanzel M, Mernberger M, Nist A, Bauer UM, Helmprobst F, Buchholz M, Roth K, Bastian L, Hartmann AM, Baldus C, Ikuta K, Neubauer A, Burchert A, Jäck HM, Klein M, Bopp T, Stiewe T, Pagenstecher A, Lohoff M

PubMed (PMID: 35459909)
Cell Death Differ.
2022
P1, P3, P4, Z

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

Schroeder MP, Bastian L, Eckert C, Gökbuget N, James AR, Tanchez JO, Schlee C, Isaakidis K, Häupl B, Baum K, Migueles Lozano OA, Kouidri K, Pan KT, Urlaub H, Schwartz S, Burmeister T, von Stackelberg A, Hoelzer D, Pfeiffer H, Rieger MA, Göllner S, Oellerich T, Horstman M, Schrappe M, Wolf J, Kirschner-Schwabe R, Brüggemann M, Müller-Tidow C, Serve H, Neumann M, Baldus CD

PubMed (PMID: 30862934)
Sci Rep
2019
P1, P3, P4, Z

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

Schroeder MP, Bastian L, Eckert C, Gökbuget N, James AR, Tanchez JO, Schlee C, Isaakidis K, Häupl B, Baum K, Migueles Lozano OA, Kouidri K, Pan KT, Urlaub H, Schwartz S, Burmeister T, von Stackelberg A, Hoelzer D, Pfeiffer H, Rieger MA, Göllner S, Oellerich T, Horstmann M, Schrappe M, Wolf J, Kirschner-Schwabe R, Brüggemann M, Müller-Tidow C, Serve H, Neumann M, Baldus CD

PubMed (PMID: 30862934)
Sci Rep
2019

Participating Institutes